The  Outcomes of Management of Necrotizing Soft Tissue- Infections in Lower Limbs of Diabetic Patients

Hasan I. Fadel  Saad; Tawfik Abuzalout; Naser  Musbah; Ahmed  Farag

doi:10.54172/mjsc.v34i1.73

Authors

Hasan I. Fadel Saad Department of Surgery, Faculty of Medicine, Omar Al Mukhtar University, El Beida, Libya
Tawfik Abuzalout Department of Surgery, Faculty of Medicine, Benghazi University, Libya
Naser Musbah Department of Surgery, Faculty of Medicine, Omar Al Mukhtar University, El Beida, Libya
Ahmed Farag Department of Surgery, Faculty of Medicine, Omar Al Mukhtar University, El Beida, Libya

DOI:

https://doi.org/10.54172/mjsc.v34i1.73

Keywords:

PVD (peripheral vascular disease), DFS (Diabetic foot syndrome), Necrotizing soft tissue infection (NSTI), patient (pts), osteomyelitis (O.M)

Abstract

Necrotizing soft tissue infection (NSTI) of the lower limb in diabetic patients (pts) is a common serious problem and is often associated with serious complications such as increased morbidity and mortality. The study aimed to assess 3 years (yrs) experience of NSTI and to review treatment and outcome in diabetic pts at Al Thoura Teaching Hospital between May 1^ST 2014 –30^th April 2017, over a period of 3 yrs.24 cases of NSTI of lower limbs in diabetic pts were admittedin the period of MAY 1^ST 2014 –30^th April 2017. Assessment and analyzing details about their presentation, clinical features, predisposing factors, treatment offered, and outcomes were performed .16 male and 8 female pts with a mean age of 56.4 yrs (range of 39- 78 yrs) were included . Majority of patients were in the age group of 50 to 70 yrs. The most important risk factors were (glycosylated HbA1c > 9.5% in 91.66%), smoking (58.33%), hypertension and hyperlipidemia (66.66% & 83.33% respectively). Neuropathy was found in 62.5% and PVD in 50%. The total involved feet are 27. The port of infection was mostly by previous unhealed feet ulcer 48.1%. The most operated surgical procedure is aggressive frequent necrectomy (51%). Multiple toes amputations and extended tarsal amputation were needed in 29.6% and 20.8% respectively. The need for grafting, flap advancement after surgical control of infection was needed in 6 cases. The failure rate of conservative surgery was 11.11%. Complete healing was in 70.37% of cases. The morbidity rate was high in all patients in this study 92.59%. The mortality rate was 3.7%. We conclude that NSTI of lower limbs is a life-threatening infective condition, common among diabetic patients, and early diagnosis with immediate and frequent surgical debridement could reduce systemic complications, morbidity, and mortality considerably.

Downloads

Download data is not yet available.

References

Abbott, C., Carrington, A., Ashe, H., Bath, S., Every, L., Griffiths, J., Johnson, K. (2002). The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort. Diabetic medicine, 19(5), 377-384. DOI: https://doi.org/10.1046/j.1464-5491.2002.00698.x

Attinger, C. E., Bulan, E., & Blume, P. A. (2000). Surgical débridement. The key to successful wound healing and reconstruction. Clinics in podiatric medicine and surgery, 17(4), 599-630.

Boulton, A. (1991). Clinical presentation and management of diabetic neuropathy and foot ulceration. Diabetic medicine, 8(S2), S52-S57. DOI: https://doi.org/10.1111/j.1464-5491.1991.tb02157.x

Boulton, A. (1996). The pathogenesis of diabetic foot problems: an overview. Diabetic medicine, 13, S12-S16. DOI: https://doi.org/10.1002/dme.1996.13.s1.12

Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005). The global burden of diabetic foot disease. The Lancet, 366(9498), 1719-1724. DOI: https://doi.org/10.1016/S0140-6736(05)67698-2

Boyko, E. J., & Lipsky, B. A. (1995). Infection and diabetes. Diabetes in America, 2, 485-499.

Durham, J. R., Lukens, M. L., Campanini, D. S., Wright, J. G., & Smead, W. L. (1991). Impact of magnetic resonance imaging on the management of diabetic foot infections. The American journal of surgery, 162(2), 150-154. DOI: https://doi.org/10.1016/0002-9610(91)90178-G

Elliott, D. C., Kufera, J. A., & Myers, R. A. (1996). Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Annals of surgery, 224(5), 672. DOI: https://doi.org/10.1097/00000658-199611000-00011

Frykberg, R. G., Wittmayer, B., & Zgonis, T. (2007). Surgical management of diabetic foot infections and osteomyelitis. Clinics in podiatric medicine and surgery, 24(3), 469-482. DOI: https://doi.org/10.1016/j.cpm.2007.04.001

Gibbons, G., & Eliopoulos, G. (1984). Infection of the diabetic foot. Kozak GP, Hoar CS Jr, Rowbotham JL, et al (Eds). Management of diabetic foot problems: Joslin Clinic and New England Deaconess Hospital: Philadelphia: WB Saunders.

Griffiths, G. (2002). Diabetic foot disease. Cuschieri SA, Essential Surgical Practice, 785-794.

Lavery, L. A., Peters, E. J., & Armstrong, D. G. (2008). What are the most effective interventions in preventing diabetic foot ulcers? International wound journal, 5(3), 425-433. DOI: https://doi.org/10.1111/j.1742-481X.2007.00378.x

Levin, M. E. (1995). Preventing amputation in the patient with diabetes. Diabetes care, 18(10), 1383-1394. DOI: https://doi.org/10.2337/diacare.18.10.1383

Mokdad, A. H., Bowman, B. A., Ford, E. S., Vinicor, F., Marks, J. S., & Koplan, J. P. (2001). The continuing epidemics of obesity and diabetes in the United States. Jama, 286(10), 1195-1200. DOI: https://doi.org/10.1001/jama.286.10.1195

Murray, H., & Boulton, A. (1995). The pathophysiology of diabetic foot ulceration. Clinics in podiatric medicine and surgery, 12(1), 1-17.

Nather, A., Bee, C. S., Huak, C. Y., Chew, J. L., Lin, C. B., Neo, S., & Sim, E. Y. (2008). Epidemiology of diabetic foot problems and predictive factors for limb loss. Journal of Diabetes and its Complications, 22(2), 77-82. DOI: https://doi.org/10.1016/j.jdiacomp.2007.04.004

Reiber, G. E., Boyko, E. J., & Smith, D. G. (1995). Lower extremity foot ulcers and amputations in diabetes. Diabetes in America, 2, 409-427.

Tesfaye, S., Chaturvedi, N., Eaton, S. E., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., . . . Fuller, J. H. (2005). Vascular risk factors and diabetic neuropathy. New England journal of medicine, 352(4), 341-350. DOI: https://doi.org/10.1056/NEJMoa032782

Wallace, G. F. (2007). Debridement of invasive diabetic foot infections. Clinics in plastic surgery, 34(4), 731-734. DOI: https://doi.org/10.1016/j.cps.2007.07.009

Yönem, A., Cakir, B., Güler, S., Azal, Ö., & Corakci, A. (2001). Effects of granulocyte‐colony stimulating factor in the treatment of diabetic foot infection. Diabetes, Obesity and Metabolism, 3(5), 332-337. DOI: https://doi.org/10.1046/j.1463-1326.2001.00142.x

Zafar, A. (2001). Management of diabetic foot-Two years experience. Journal of Ayub Medical College Abbottabad, 13(1), 14-16.